Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.
Kawai A, Araki N, Sugiura H, Ueda T, Yonemoto T, Takahashi M, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Tanase T, Hasegawa T, Takahashi S. Kawai A, et al. Among authors: kunisada t. Lancet Oncol. 2015 Apr;16(4):406-16. doi: 10.1016/S1470-2045(15)70098-7. Epub 2015 Mar 18. Lancet Oncol. 2015. PMID: 25795406 Clinical Trial.
Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.
Morioka H, Takahashi S, Araki N, Sugiura H, Ueda T, Takahashi M, Yonemoto T, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Susa M, Nakayama R, Nishimoto K, Kikuta K, Horiuchi K, Kawai A. Morioka H, et al. Among authors: kunisada t. BMC Cancer. 2016 Jul 14;16:479. doi: 10.1186/s12885-016-2511-y. BMC Cancer. 2016. PMID: 27418251 Free PMC article. Clinical Trial.
Efficacy of Trabectedin in Patients with Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II Studies.
Takahashi M, Takahashi S, Araki N, Sugiura H, Ueda T, Yonemoto T, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Shimura M, Kawai A. Takahashi M, et al. Among authors: kunisada t. Oncologist. 2017 Aug;22(8):979-988. doi: 10.1634/theoncologist.2016-0064. Epub 2017 May 18. Oncologist. 2017. PMID: 28526720 Free PMC article. Clinical Trial.
p53-armed oncolytic virotherapy induces abscopal effect in osteosarcoma by promoting immunogenic cell death.
Demiya K, Tazawa H, Kondo H, Kure M, Mochizuki Y, Komatsubara T, Yoshida A, Uotani K, Hasei J, Fujiwara T, Kunisada T, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Demiya K, et al. Among authors: kunisada t. Mol Ther Oncol. 2024 Jun 29;32(3):200845. doi: 10.1016/j.omton.2024.200845. eCollection 2024 Sep 19. Mol Ther Oncol. 2024. PMID: 39108499 Free PMC article.
Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy.
Araki N, Takahashi S, Sugiura H, Ueda T, Yonemoto T, Takahashi M, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Kawai A. Araki N, et al. Among authors: kunisada t. Eur J Cancer. 2016 Mar;56:122-130. doi: 10.1016/j.ejca.2015.12.014. Epub 2016 Feb 2. Eur J Cancer. 2016. PMID: 26845175 Free article.
Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials.
Endo M, Takahashi S, Araki N, Sugiura H, Ueda T, Yonemoto T, Takahashi M, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Goda K, Kawai A. Endo M, et al. Among authors: kunisada t. Cancer Med. 2020 Jun;9(11):3656-3667. doi: 10.1002/cam4.2991. Epub 2020 Mar 27. Cancer Med. 2020. PMID: 32220056 Free PMC article.
Soft-tissue sarcoma in adolescents and young adults.
Kunisada T, Nakata E, Fujiwara T, Hosono A, Takihira S, Kondo H, Ozaki T. Kunisada T, et al. Int J Clin Oncol. 2023 Jan;28(1):1-11. doi: 10.1007/s10147-022-02119-7. Epub 2022 Jan 27. Int J Clin Oncol. 2023. PMID: 35084598 Review.
351 results